Dynavax Technologies
DVAX
$11.20
Share price
1.08%
Change (1 day)
-5.56%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total debt
Total debt on the balance sheet as of December 2022 : $0.25 B
According to Dynavax Technologies 's latest financial reports the company's total debt is $0.25 B. A company’s total debt is the sum of all current and non-current debts.
Dynavax Technologies - Total debt on balance sheet (from 2009 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.25 B | 0.24% |
| 2021-12-31 | $0.25 B | 18.15% |
| 2020-12-31 | $0.21 B | 0.65% |
| 2019-12-31 | $0.21 B | 114.58% |
| 2018-12-31 | $0.10 B | |
| 2014-12-31 | $9.55 M | |
| 2012-12-31 | $N/A | -100% |
| 2011-12-31 | $12.81 M | 8.73% |
| 2010-12-31 | $11.78 M | 26.12% |
| 2009-12-31 | $9.34 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $34.87 B | 13,414.98% | 🇺🇸 USA |
 Amgen AMGN | $61.59 B | 23,773.11% | 🇺🇸 USA |
 Biogen BIIB | $6.60 B | 2,461.80% | 🇺🇸 USA |
 Gilead Sciences GILD | $25.23 B | 9,682.18% | 🇺🇸 USA |
 Merck MRK | $30.69 B | 11,795.28% | 🇺🇸 USA |
 AstraZeneca AZN | $31.50 B | 12,109.99% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $25.89 B | 9,936.67% | 🇬🇧 UK |
 Agenus
AGEN | $78.42 M | -69.60% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $21.56 B | 8,256.65% | 🇮🇱 Israel |